Quantcast
Channel: WN.com - Articles related to Noven Receives FDA Approval for Brisdelle™ (Paroxetine) Capsules, the First Nonhormonal Therapy for Vasomotor Symptoms Associated with Menopause
Viewing all articles
Browse latest Browse all 189

Non-hormonal treatment for hot flashes gains FDA approval

$
0
0
“There are a significant number of women who suffer from hot flashes associated with menopause and who cannot or do not want to use hormonal treatments. This new approval provides them with a new therapeutic option to help ease their discomfort,” stated Hylton V. Joffe, M.D., M.M.Sc., director of the Division of Bone, Reproductive and Urologic Products in the FDA’s Center for Drug Evaluation and Research. Hot flashes, which affect approximately 75% of all menopausal women are caused when the blood vessels closed to the surface of the skin become dilated to cool, causing the women to perspire profusely and become flushed. In addition, many sufferers also report having accelerated heartbeats...

Viewing all articles
Browse latest Browse all 189

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>